OBS AGP (Pvt.) Limited
Syed Furqan Ali is a seasoned professional with extensive experience in brand and product management within the pharmaceutical industry. Currently serving as a Senior Brand Manager at OBS AGP (Pvt.) Limited since February 2023, Syed previously held similar roles at Hilton Pharma Limited and TABROS PHARMA (Pvt) Ltd., where notable achievements include successful cardiology campaigns and product launches. Earlier positions with Wilshire Labs involved launching products in the skin, cancer, and immunity sectors, attaining significant revenue within just months. Additionally, Syed's experience includes roles at SAMI Pharmaceuticals, Graton Pharma, and Pfizer, where responsibilities ranged from KOL development to market research and strategic planning. Syed holds an MBA in Marketing and Finance from the Shaheed Zulfikar Ali Bhutto Institute of Science and Technology and a Doctor of Pharmacy degree from Karachi University.
OBS AGP (Pvt.) Limited
OBS AGP began its commercial operations in 2021 as an independent pharmaceutical company in Karachi, Pakistan. OBS Group, through its subsidiary AGP Limited acquired a selected portfolio of products which are commercialized in Pakistan under the Sandoz brand. This acquisition includes some widely used brands such as Azomax, Zatofen and Amoxi-Clav, which are owned by Sandoz AG, a company organized under the laws of Switzerland.